SHARE @ Advocate Health - Midwest - Scientific Day: Botulism: Delayed Recognition
 

Affiliations

Aurora Sinai Medical Center, Aurora St. Luke's Medical Center

Abstract

Introduction/Background:

Botulism is caused by botulinum neurotoxin (BONT), produced by the anaerobe Clostridium botulinum which causes descending paralysis due to irreversible blockade of pre-synaptic acetylcholine release. Forms include foodborne, infant, wound and iatrogenic. Foodborne botulism is uncommon in the United States and due to improper food preservation, resulting in bacterial contamination, growth and toxin production. Treatment is with botulinum antitoxin (BAT) which binds unbound toxin.

Description:

62-year-old F presented to the Emergency Department (EDP) with GI and neurological complaints 16h after ingesting broccoli cheddar soup (single-serving plastic package, commercially prepared). No PMH or medications. Alert, fully oriented, normal strength. BP 225/106. Sinus tachycarida 120 bpm. Otherwise normal exam. EDP +3h: Neurologist described “heaviness around her eyes and generalized fatigue.” Full visual fields, reactive pupils, conjugated gaze, but significant ophthalmoplegia. Face symmetric, decreased smiling. Dysarthric and dysphonic speech was difficult to understand. Strength decreased: arms 4+/5 and legs 1+/5. Reflexes decreased by 1+. EDP +4h: Transferred to ICU. Desaturation, severe hypercapnia and respiratory acidosis prompted tracheal intubation and mechanical ventilation. The differential diagnosis included Guillan-Barré Syndrome and variants such as Miller Fisher Syndrome, stroke and myasthenia gravis. Myelitis and tick-borne disease seemed improbable. Evaluation included CT head and neck, CBC, chemistries, MRI x2, CT head, EEG and lumbar puncture—all (-) as were cultures, meningitis panel, GM1, GD1b and GC1b antibodies. EDP+5d: Patient paralyzed. History from husband emphasized baseline high-energy state. He mentioned “eyelid heaviness” and diplopia, indicating descending paralysis and the possibility of botulism. CDC and WI Department of Health Services were consulted. Plasma and stool sampling were approved for testing and heptavalent BAT was released by the CDC and infused. EDP +10d: PCR for BONT type A (+). Subsequently, BoNT type A was confirmed by mouse bioassay. EDP +122d: Awake, moving digits, mechanically ventilated in long-term acute care hospital.

Discussion:

Our patient with food-borne botulism presented atypically: Urban, industrialized, sealed plastic container, spoiled taste inconsistent with contamination by C. botulinum as the toxin has no odor or taste. Botulism should be considered early in the differential of descending paralysis and prompt consultation with DPS to request BAT. Only BAT-eligible patients undergo botulism testing.

Presentation Notes

Presented at Scientific Day; May 21, 2025; Park Ridge, IL.

Full Text of Presentation

wf_yes

Document Type

Poster


 

Open Access

Available to all.

Share

COinS
 
May 21st, 11:41 AM May 21st, 1:15 PM

Botulism: Delayed Recognition

Introduction/Background:

Botulism is caused by botulinum neurotoxin (BONT), produced by the anaerobe Clostridium botulinum which causes descending paralysis due to irreversible blockade of pre-synaptic acetylcholine release. Forms include foodborne, infant, wound and iatrogenic. Foodborne botulism is uncommon in the United States and due to improper food preservation, resulting in bacterial contamination, growth and toxin production. Treatment is with botulinum antitoxin (BAT) which binds unbound toxin.

Description:

62-year-old F presented to the Emergency Department (EDP) with GI and neurological complaints 16h after ingesting broccoli cheddar soup (single-serving plastic package, commercially prepared). No PMH or medications. Alert, fully oriented, normal strength. BP 225/106. Sinus tachycarida 120 bpm. Otherwise normal exam. EDP +3h: Neurologist described “heaviness around her eyes and generalized fatigue.” Full visual fields, reactive pupils, conjugated gaze, but significant ophthalmoplegia. Face symmetric, decreased smiling. Dysarthric and dysphonic speech was difficult to understand. Strength decreased: arms 4+/5 and legs 1+/5. Reflexes decreased by 1+. EDP +4h: Transferred to ICU. Desaturation, severe hypercapnia and respiratory acidosis prompted tracheal intubation and mechanical ventilation. The differential diagnosis included Guillan-Barré Syndrome and variants such as Miller Fisher Syndrome, stroke and myasthenia gravis. Myelitis and tick-borne disease seemed improbable. Evaluation included CT head and neck, CBC, chemistries, MRI x2, CT head, EEG and lumbar puncture—all (-) as were cultures, meningitis panel, GM1, GD1b and GC1b antibodies. EDP+5d: Patient paralyzed. History from husband emphasized baseline high-energy state. He mentioned “eyelid heaviness” and diplopia, indicating descending paralysis and the possibility of botulism. CDC and WI Department of Health Services were consulted. Plasma and stool sampling were approved for testing and heptavalent BAT was released by the CDC and infused. EDP +10d: PCR for BONT type A (+). Subsequently, BoNT type A was confirmed by mouse bioassay. EDP +122d: Awake, moving digits, mechanically ventilated in long-term acute care hospital.

Discussion:

Our patient with food-borne botulism presented atypically: Urban, industrialized, sealed plastic container, spoiled taste inconsistent with contamination by C. botulinum as the toxin has no odor or taste. Botulism should be considered early in the differential of descending paralysis and prompt consultation with DPS to request BAT. Only BAT-eligible patients undergo botulism testing.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.